KEGG   DRUG: Etigilimab
Entry
D11593                      Drug                                   
Name
Etigilimab (USAN/INN)
Formula
C6452H9966N1714O2012S40
Exact mass
144929.9042
Mol weight
145019.11
Sequence
(Heavy chain)
QVQLQESGPG LVKPSETLSL TCAVSGYSIT SDYAWNWIRQ PPGKGLEWIG YISYSGSTSY
NPSLRSRVTI SRDTSKNQFF LKLSSVTAAD TAVYYCARRQ VGLGFAYWGQ GTLVTVSSAS
TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKRVEPKS CDKTHTCPPC PAPELLGGPS
VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSREEMT
KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
GNVFSCSVMH EALHNHYTQK SLSLSPGK
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCKASQDVS TAVAWYQQKP GKAPKLLIYS ASYRYTGVPS
RFSGSGSGTD FTFTISSLQP EDIATYYCQQ HYSTPWTFGQ GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSNTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H145-H201, H221-L214, H227-H'227, H230-H'230, H262-H322, H368-H426, H'22-H'96, H'145-H'201, H'221-L'214, H'262-H'322, H'368-H'426, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Class
Antineoplastic
 DG02938  Immune checkpoint inhibitor
Efficacy
Antineoplastic, Immune checkpoint inhibitor, Anti-TIGIT receptor antibody
  Type
Monoclonal antibody
Comment
Treatment of cancer
Target
TIGIT [HSA:201633] [KO:K16350]
  Pathway
hsa04514  Cell adhesion molecules
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG02938  Immune checkpoint inhibitor
   D11593  Etigilimab
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   Immune checkpoints
    TIGIT
     D11593  Etigilimab (USAN/INN)
Other DBs
CAS: 2044984-83-8
PubChem: 405226460
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system